Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Orexo AB
C5GCurrent price
0.88 EUR
+0.003 EUR (+0.34%)
Last closed
11 SEK
Company
www.orexo.com
ISIN
SE0000736415
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
Frankfurt Exchange
Capitalization
377 860 385 SEK
Yield for 12 month
-29.23 %
1Y
3Y
5Y
10Y
15Y
C5G
Orexo AB (publ), a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, European Union, and internationally. Its products include Zubsolv tablets for the treatment of opioid use disorder; Abstral for the treatment of breakthrough pain in cancer patients; and Edluar for the treatment of insomnia. The company is developing OX124 for opioid overdose; OX125 for rescue medication and opioid overdose; OX640 for emergency treatment of allergic reactions; and OX-MPI for the treatment of endometriosis. In addition, its digital therapies include deprexis for the treatment of depression; vorvida for alcohol management; and modia for opioid use disorder. Orexo AB (publ) was founded in 1994 and is headquartered in Uppsala, Sweden. Address: Rapsgatan 7E, Uppsala, Sweden
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
534.84 SEKP/E ratio
–Dividend Yield
–Current Year
+636 970 621 SEK
Last Year
+622 512 153 SEK
Current Quarter
+136 109 093 SEK
Last Quarter
+153 558 980 SEK
Current Year
+471 446 006 SEK
Last Year
+520 205 969 SEK
Current Quarter
+116 066 657 SEK
Last Quarter
+116 565 222 SEK
Key Figures C5G
1 year
3 years
5 years
10 years
EBITDA
67 605 840 SEK
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
1.12 %
PEG Ratio
–
Return On Equity TTM
-325 %
Wall Street Target Price
534.84 SEK
Revenue TTM
593 994 020 SEK
Book Value
-0.79 SEK
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-12.6 %
Dividend Yield
–
Gross Profit TTM
520 205 971 SEK
Earnings per share
-3.1 SEK
Diluted Eps TTM
-3.1 SEK
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
485 %
Profit Margin
-17.68 %
Dividend Analytics C5G
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History C5G
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1904:1903
Payout Ratio
–
Last Split Date
31.05.2011
Dividend Date
–
Stock Valuation C5G
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
9.1575
Enterprise Value Revenue
1.4186
Price Sales TTM
0.6361
Enterprise Value EBITDA
19.6066
Price Book MRQ
21.0683
Financials C5G
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators C5G
For 52 weeks
10.57 SEK
23.23 SEK
50 Day MA
13.92 SEK
Shares Short Prior Month
–
200 Day MA
16.43 SEK
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart